Stock 600812 NORTH CHINA PHARMACEUTICAL COMPANY.LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company North China Pharmaceutical Company.Ltd

Equities

600812

CNE000000D16

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-06 pm EDT 		5-day change 1st Jan Change
5.27 CNY -0.57% Intraday chart for North China Pharmaceutical Company.Ltd +2.53% -7.54%
Apr. 25 North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 30 North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million CI

Business Summary

North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 10,159

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical Preparation Medicine
42.5 %
4,600 43.8 % 4,301 42.5 % -6.51%
Chemical Raw Materials
24.7 %
2,288 21.8 % 2,498 24.7 % +9.20%
Biological Agents
15.7 %
1,696 16.2 % 1,593 15.7 % -6.07%
Medicine and Other Logistics Trade
7.6 %
828 7.9 % 772 7.6 % -6.81%
Pharmaceutical Intermediate
7.1 %
601 5.7 % 719 7.1 % +19.65%
Others
1.9 %
436 4.2 % 187 1.9 % -57.02%
Other Business
0.5 %
51 0.5 % 50 0.5 % -1.70%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
85.8 %
8,860 84.8 % 8,639 85.8 % -2.50%
International
14.2 %
1,589 15.2 % 1,431 14.2 % -9.92%

Managers

Managers TitleAgeSince
Xin Yan Liu CEO
 Chief Executive Officer 54 18-08-27
Jian Jun Li DFI
 Director of Finance/CFO 53 09-08-31
Suo Qing Zhang BRD
 Director/Board Member 54 20-01-31
Fan Li BRD
 Director/Board Member 42 12-12-31
Jing Yang IRC
 Investor Relations Contact - -
Zhi Shan Chang SEC
 Corporate Secretary 53 12-12-31
Ren Long Gao PRN
 Corporate Officer/Principal 57 07-04-24

Members of the board

Members of the board TitleAgeSince
Guang Cheng Pan BRD
 Director/Board Member 75 19-05-21
De Min Zhou BRD
 Director/Board Member 58 19-05-21
Ji Gang Xie BRD
 Director/Board Member 51 21-04-22
Xin Yan Liu CEO
 Chief Executive Officer 54 18-08-27
Wen Zan Gao BRD
 Director/Board Member 52 22-10-11
Ren Tao Song BRD
 Director/Board Member 57 23-03-26
Xiu Jun Wang BRD
 Director/Board Member 57 22-10-11
Wei Lu CHM
 Chairman 58 22-10-11
Li Jun Yang BRD
 Director/Board Member 50 22-10-11
Suo Qing Zhang BRD
 Director/Board Member 54 20-01-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,715,730,370 717,110,710 ( 41.80 %) 0 41.80 %

Shareholders

NameEquities%Valuation
Hebei State-Owned Assets Supervision & Admin. Commission
27.33 %
445,692,702 27.33 % 293 M ¥
JIZHONG ENERGY RESOURCES CO., LTD.
25.33 %
413,080,473 25.33 % 271 M ¥
China Investment Corp. (Investment Management)
3.367 %
54,916,601 3.367 % 36 M ¥
Da Cheng Fund Management Co., Ltd.
1.009 %
16,453,800 1.009 % 11 M ¥
Yinhua Fund Management Co., Ltd.
0.9863 %
16,084,499 0.9863 % 11 M ¥
Harvest Fund Management Co., Ltd.
0.8384 %
13,672,800 0.8384 % 9 M ¥
Cinda Fund Management Co. Ltd.
0.5277 %
8,606,181 0.5277 % 6 M ¥
Fullgoal Fund Management Co., Ltd.
0.1614 %
2,632,336 0.1614 % 2 M ¥
China Asset Management Co., Ltd.
0.0985 %
1,605,700 0.0985 % 1 M ¥
China Merchants Fund Management Co., Ltd.
0.0976 %
1,590,900 0.0976 % 1 M ¥
NameEquities%Valuation
Hebei State-Owned Assets Supervision & Admin. Commission
100.00 %
84,925,641 100.00 % 56 M ¥

Company contact information

North China Pharmaceutical Co., Ltd.

388 Heping East Road

050015, Shijiazhuang

+86 311 8599 3999

http://www.ncpc.com
address North China Pharmaceutical Company.Ltd(600812)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
NORTH CHINA PHARMACEUTICAL COMPANY.LTD Stock North China Pharmaceutical Company.Ltd
-7.54% 1.26B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.98% 690B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.43% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.01% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.22% 323B
ABBVIE INC. Stock AbbVie Inc.
+4.75% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.32% 235B
NOVARTIS AG Stock Novartis AG
+5.79% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.49% 195B
AMGEN INC. Stock Amgen Inc.
+4.10% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600812 Stock
  4. Company North China Pharmaceutical Company.Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW